Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Pharma Industry News Briquilimab shows promising asthma signal in ETESIAN study as Jasper Therapeutics resolves BEACON probe Discover how Jasper Therapeutics reignited confidence in briquilimab with new asthma data and a clarified BEACON investigation. bySoujanya RaviDecember 2, 2025